Co-delivery of vascular endothelial growth factor and angiopoietin-1 using injectable microsphere/hydrogel hybrid systems for therapeutic angiogenesis

Pharmaceutical Research

Volumn 30, Issue 8, 2013, Pages 2157-2165

  Shin, Seung Hwa ^a   Lee, Jangwook ^a   Ahn, Dong Gyun ^a   Lee, Kuen Yong ^a  

^a Hanyang University   (South Korea)

Author keywords

angiogenesis; angiopoietin 1; microsphere hydrogel hybrid system; vascular endothelial growth factor

Indexed keywords

ALGINIC ACID; ANGIOGENIC FACTOR; ANGIOPOIETIN 1; CD31 ANTIGEN; MICROSPHERE; POLYGLYCOLIC ACID; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; EMULSION; FEMALE; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; HYDROGEL; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; MUSCLE TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; TISSUE SECTION; TWO HYBRID SYSTEM; WESTERN BLOTTING;

ALGINATES; ANGIOPOIETIN-1; ANIMALS; CELL PROLIFERATION; DELAYED-ACTION PREPARATIONS; FEMALE; GLUCURONIC ACID; HEXURONIC ACIDS; HINDLIMB; HYDROGEL; LACTIC ACID; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSPHERES; NEOVASCULARIZATION, PHYSIOLOGIC; POLYGLYCOLIC ACID; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84879794813     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-013-1076-6     Document Type: Article

References (35)

1. Gaziano TA. Cardiovascular disease in the developing world and its cost-effective management. Circulation. 2005;112:3547-53.
2. Choi D, Hwang K-C, Lee K-Y, Kim Y-H. Ischemic heart diseases: current treatments and future. J Control Release. 2009;140:194-202.
3. Emanueli C, Madeddu P. Angiogenesis gene therapy to rescue ischaemic tissues: achievements and future directions. Br J Pharmacol. 2001;133:951-8.
4. Khan TA, Sellke FW, Laham RJ. Therapeutic angiogenesis: protein-based therapy for coronary artery disease. Expert Opin Pharmacol. 2003;4:219-26.
5. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Circulation. 2004;109:2692-7.
6. Tomanek RJ, Holifield JS, Reiter RS, Sandra A, Lin JJC. Role of VEGF family members and receptors in coronary vessel formation. Dev Dyn. 2002;225:233-40.
7. Zachary I, Mathur A, Yla-Herttuala S, Martin J. Vascular protection: a novel nonangiogenic cardiovascular role for vascular endothelial growth factor. Arterioscler Thromb Vas. 2000;20:1512-20.
8. Springer ML, Chen AS, Kraft PE, Bednarski M, Blau HM. VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol Cell. 1998;2:549-58.
9. Chen J-X, Stinnett A. Disruption of ang-1/tie-2 signaling contributes to the impaired myocardial vascular maturation and angiogenesis in type II diabetic mice. Arterioscler Thromb Vas. 2008;28:1606-13.
10. Kim I, Moon S-O, Park SK, Chae SW, Koh GY. Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-Selectin expression. Circ Res. 2001;89:477-9.
11. Manning M, Chou D, Murphy B, Payne R, Katayama D. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27:544-75.
12. Lee KY, Yuk SH. Polymeric protein delivery systems. Prog Polym Sci. 2007;32:669-97.
13. Lee KY, Mooney DJ. Hydrogels for tissue engineering. Chem Rev. 2001;101:1869-80.
14. Tanaka Y, Gong JP, Osada Y. Novel hydrogels with excellent mechanical performance. Prog Polym Sci. 2005;30:1-9.
15. Lee KY, Mooney DJ. Alginate: properties and biomedical applications. Prog Polym Sci. 2012;37:106-26.
16. Lee KY, Peters MC, Mooney DJ. Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice. J Control Release. 2003;87:49-56.
17. Lee KW, Yoon JJ, Lee JH, Kim SY, Jung HJ, Kim SJ, et al. Sustained release of vascular endothelial growth factor from calcium-induced alginate hydrogels reinforced by heparin and chitosan. Transplant Proc. 2004;36:2464-5.
18. Freeman I, Cohen S. The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization. Biomaterials. 2009;30:2122-31.
19. Lee J, Bhang S, Park H, Kim B-S, Lee K. Active blood vessel formation in the ischemic hindlimb mouse model using a microsphere/hydrogel combination system. Pharm Res. 2010;27:767-74.
20. Lee J, Tan CY, Lee S-K, Kim Y-H, Lee KY. Controlled delivery of heat shock protein using an injectable microsphere/hydrogel combination system for the treatment of myocardial infarction. J Control Release. 2009;137:196-202.
21. Lee J, Lee KY. Injectable microsphere/hydrogel combination systems for localized protein delivery. Macromol Biosci. 2009;9:671-6.
22. Lee J, Oh YJ, Lee SK, Lee KY. Facile control of porous structures of polymer microspheres using an osmotic agent for pulmonary delivery. J Control Release. 2010;146:61-7.
23. Yang Y-Y, Chung T-S, Ping NN. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials. 2001;22:1231-41.
24. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 2001;48:139-57.
25. Simons M, Ware JA. Therapeutic angiogenesis in cardiovascular disease. Nat Rev Drug Discov. 2003;2:863-71.
26. Peters KG, Kontos CD, Lin PC, Wong AL, Rao P, Huang L, et al. Functional significance of Tie2 signaling in the adult vasculature. Recent Prog Horm Res. 2004;59:51-71.
27. Saharinen P, Eklund L, Miettinen J, Wirkkala R, Anisimov A, Winderlich M, et al. Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol. 2008;10:527-37.
28. Borselli C, Storrie H, Benesch-Lee F, Shvartsman D, Cezar C, Lichtman JW, et al. Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc Natl Acad Sci. 2010;107:3287-92.
29. Jeon O, Kang S-W, Lim H-W, Choi D, Kim D-I, Lee SH, et al. Synergistic effect of sustained delivery of basic fibroblast growth factor and bone marrow mononuclear cell transplantation on angiogenesis in mouse ischemic limbs. Biomaterials. 2006;27:1617-25.
30. Nagy JA, Dvorak AM, Dvorak HF. VEGF-A164/165 and PlGF: roles in angiogenesis and arteriogenesis. Trends Cardiovasc Med. 2003;13:169-75.
31. Chen R, Silva E, Yuen W, Mooney D. Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res. 2007;24:258-64.
32. Arsic N, Zentilin L, Zacchigna S, Santoro D, Stanta G, Salvi A, et al. Induction of functional neovascularization by combined VEGF and Angiopoietin-1 gene transfer using AAV vectors. Mol Ther. 2003;7:450-9.
33. Ye L, Haider HK, Jiang S, Tan RS, Ge R, Law PK, et al. Improved angiogenic response in pig heart following ischemic injury using human skeletal myoblast simultaneously expressing VEGF165 and angiopoietin-1. Eur J Heart Fail. 2007;9:15-22.
34. Samuel SM, Akita Y, Paul D, Thirunavukkarasu M, Zhan L, Sudhakaran PR, et al. Coadministration of adenoviral vascular endothelial growth factor and angiopoietin-1 enhances vascularization and reduces ventricular remodeling in the infarcted myocardium of type 1 diabetic rats. Diabetes. 2010;59:51-60.
35. Su H, Takagawa J, Huang Y, Arakawa-Hoyt J, Pons J, Grossman W, et al. Additive effect of AAV-mediated angiopoietin-1 and VEGF expression on the therapy of infarcted heart. Int J Cardiol. 2009;133:191-7.